Abstract
Transcription factors regulate the expression of multiple inflammatory genes and play a pivotal role in chronic inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Prominent transcription factors in airway diseases include nuclear factor-κB (NF-κB) and activator protein-1 (AP-1), which together regulate the expression of multiple inflammatory proteins. Glucocorticoids activate glucocorticoid receptors (GR), which act as transcription factors and inhibit transcription induced by NF-κB and AP-1. Activation of genes involves hyperacetylation of core histones to open up the chromatin structure to initiate transcription. GR recruit histone deacetylase-2 (HDAC2) to the activated inflammatory gene to switch off transcription. In COPD, there is a marked reduction in HDAC2 expression, resulting in glucocorticoid resistance. Therapeutic implications, which may be generalized to all inflammatory diseases, are discussed. © 2006 USCAP, Inc All rights reserved.
Cite
CITATION STYLE
Barnes, P. J. (2006, September 5). Transcription factors in airway diseases. Laboratory Investigation. Nature Publishing Group. https://doi.org/10.1038/labinvest.3700456
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.